21-JAN-2026 6:12

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1033 22 1148 87 1059 161 980
ERLYTX 84 0 0 3 37 6 37
GI 189 2 104 10 122 21 128
GU 416 3 157 20 244 44 268
LEUK 141 3 157 10 122 22 134
LUNG 177 6 313 15 183 32 195
LYMPH 394 3 157 17 207 45 274
MELAN 273 0 0 0 0 1 6
MMYEL 129 1 52 6 73 11 67
MULT 23 0 0 1 12 8 49
OTHER 41 0 0 4 49 7 43
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 2904 40 2088 173 2108 358 2181

21-JAN-2026 6:12

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 119 1 52 11 134 24 146
ERLYTX 10 0 0 0 0 0 0
LEUK 660 10 522 44 536 91 554
LUNG 322 7 365 25 304 53 323
OTHER 36 1 52 2 24 5 30
PEOLC 128 0 0 3 37 17 103
PREV 218 7 365 22 268 44 268
SURV 18 0 0 0 0 2 12
SXQOL 538 4 209 34 414 75 457
Total 2049 30 1565 141 1717 311 1893

21-JAN-2026 6:12

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1033 22 1148 87 1059 161 980
CCD 119 1 52 11 134 24 146
ERLYTX 94 0 0 3 37 6 37
GI 189 2 104 10 122 21 128
GU 416 3 157 20 244 44 268
LEUK 801 13 678 54 657 113 688
LUNG 499 13 678 40 487 85 517
LYMPH 394 3 157 17 207 45 274
MELAN 273 0 0 0 0 1 6
MMYEL 129 1 52 6 73 11 67
MULT 23 0 0 1 12 8 49
OTHER 77 1 52 6 73 12 73
PEOLC 128 0 0 3 37 17 103
PREV 220 7 365 22 268 44 268
SURV 18 0 0 0 0 2 12
SXQOL 540 4 209 34 414 75 457
Total 4953 70 3652 314 3824 669 4073

21-JAN-2026 6:12

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 654 17 887 63 767 110 670
ERLYTX 46 0 0 2 24 4 24
GI 135 1 52 6 73 14 85
GU 352 3 157 20 244 39 237
LEUK 86 3 157 7 85 17 103
LUNG 110 1 52 8 97 15 91
LYMPH 254 1 52 13 158 33 201
MELAN 172 0 0 0 0 1 6
MMYEL 80 0 0 4 49 8 49
MULT 8 0 0 0 0 2 12
OTHER 41 0 0 4 49 7 43
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 1942 26 1357 127 1546 250 1521

21-JAN-2026 6:12

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 106 1 52 9 110 21 128
ERLYTX 10 0 0 0 0 0 0
LEUK 285 3 157 16 195 33 201
LUNG 199 1 52 12 146 30 183
OTHER 35 0 0 1 12 4 24
PEOLC 91 0 0 3 37 14 85
PREV 213 2 104 17 207 39 237
SURV 18 0 0 0 0 2 12
SXQOL 362 2 104 25 304 53 323
Total 1319 9 469 83 1011 196 1193

21-JAN-2026 6:12

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 838 20 1044 78 950 130 791
CCD 144 2 104 14 170 25 152
ERLYTX 56 0 0 2 24 4 24
GI 137 1 52 6 73 13 79
GU 374 5 261 23 280 45 274
LEUK 371 6 313 23 280 50 304
LUNG 314 2 104 24 292 49 298
LYMPH 254 1 52 13 158 33 201
MELAN 172 0 0 0 0 1 6
MMYEL 65 0 0 4 49 8 49
MULT 25 0 0 2 24 4 24
OTHER 252 3 157 14 170 33 201
PEOLC 92 1 52 4 49 14 85
PREV 215 2 104 17 207 39 237
SURV 18 0 0 0 0 2 12
SXQOL 364 2 104 25 304 53 323
Total 3691 45 2347 249 3030 503 3060

21-JAN-2026 6:12

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 862 16 835 66 804 121 737
ERLYTX 80 0 0 3 37 6 37
GI 109 2 104 6 73 12 73
GU 244 2 104 15 183 33 201
LEUK 108 2 104 6 73 12 73
LUNG 140 4 209 11 134 25 152
LYMPH 320 2 104 14 170 35 213
MMYEL 116 1 52 4 49 9 55
MULT 23 0 0 1 12 8 49
Total 2002 29 1512 126 1535 261 1590

21-JAN-2026 6:12

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1913 22 1148 120 1461 269 1638
AFFIL 129 1 52 13 158 27 164
CCOP/NCORP 1219 12 626 77 937 150 913
Non-SWOG 1682 25 1304 94 1144 213 1297
Total 4943 60 3130 304 3700 659 4012

21-JAN-2026 6:12

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GI S2433 PANC, KRAS WT, Met, SOC Chemo +/- Panitumumab 1 Y 26-DEC-25

21-JAN-2026 6:12

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GU S2200 pRCC, Adv, Cabo ± Atezo 1 T 16-JAN-26
MELAN EA6141 Melan, Adv, Nivolumab+Ipi ± Sargmostim 1 E 08-JAN-26
OTHER EA3161 HNC, HPV+ OPCA, (cisplatin+RT) +/- Nivo 1 E 07-JAN-26
OTHER EA3161 HNC, HPV+ OPCA, (cisplatin+RT) +/- Nivo 2 E 07-JAN-26
GI A021806 Pancreas, Perioperative vs Adjuvant Chemo 0 E 05-JAN-26
GI A021806 Pancreas, Perioperative vs Adjuvant Chemo 1 E 05-JAN-26

21-JAN-2026 6:12

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 13
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 13
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 10
LUNG LUNGMAP NSCLC, Adv, Master 1 7
BREAST A012301 Breast, Early Stg, Tamoxifen 1 6
PREV A212102 Blind Ref Set for Multicancer Early Detection 1 5
LYMPH AHOD2131 cHL,StgI-II,StdTherapyvImmuno-oncologyTherapy 2 3
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 3
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 3